Placebo Effect of Immediate Kinesio Taping on Upper Extremity Performance in Healthy Adults (KT-PLACEBO)

April 6, 2026 updated by: Abeer Mohamed Abdulla Sayed, Istinye University

Immediate Effects of Kinesio Taping on Upper Extremity Motor Performance and Perceived Function in Healthy Adults: A Sham-controlled Randomized Study

This study investigates whether Kinesio Taping has immediate effects on upper extremity performance in healthy adults and whether these effects may be influenced by placebo mechanisms. Participants are randomly assigned to one of three groups: therapeutic Kinesio Taping, sham Kinesio Taping, or no intervention.

All participants complete tests of hand function, including grip strength, typing performance, reaction time, and manual dexterity, before and after a short standardized waiting period. Participants also rate their perceived performance, comfort, and overall change.

The purpose of this study is to determine whether improvements in performance are due to the mechanical effects of the tape or related to sensory and expectation-based (placebo) factors.

Study Overview

Detailed Description

This study is a single-blind, three-arm randomized controlled trial designed to investigate the immediate effects of Kinesio Taping on upper extremity motor performance and perceived function in healthy adults, and to explore the potential contribution of placebo-related mechanisms. Participants are randomly assigned to one of three groups: therapeutic Kinesio Taping applied with tension, sham Kinesio Taping applied without tension, or a no-intervention control condition.

The intervention targets the wrist extensor musculature of the dominant upper extremity. Both taping conditions follow the same application procedure and positioning, differing only in the level of tension to isolate the mechanical versus perceptual effects of the tape. The control group follows the same testing timeline without receiving any intervention.

Outcome measures are collected at baseline and immediately after a standardized 20-minute waiting period. Objective measures include maximal grip strength, typing performance, choice reaction time, and manual dexterity. Subjective measures include perceived performance, task ease, comfort, and global rating of change.

The study is conducted in a controlled and standardized testing environment with consistent equipment, procedures, and instructions across participants. This design allows for the comparison of objective performance outcomes with subjective perceptions, providing insight into the relationship between mechanical and placebo effects in Kinesio Taping applications.

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Abeer Mohamed Abdulla Sayed, BSc (Physiotherapy and Rehabil
  • Phone Number: +974 33686496 +90 552 872 2754
  • Email: 2433095052@stu.istinye.edu.tr

Study Locations

    • Istanbul
      • Istanbul, Istanbul, Turkey (Türkiye), 34010
        • Istinye University Physiotherapy and Rehabilitation Application and Research Center (ISUFIZYOTEM)
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being healthy adult between 18-40 years
  • No current pain or injury in the dominant upper extremity
  • No history of chronic musculoskeletal conditions affecting the upper extremity
  • Ability to read, understand, and provide informed consent
  • Regular use of a standard keyboard and mouse, with a minimum self-reported typing frequency of ≥5 hours per week, ensuring familiarity with digital typing tasks and adequate baseline fine motor coordination.

Exclusion Criteria:

  • Respiratory, neurological, or cardiovascular disorders
  • History of surgery or fracture in the dominant upper extremity within the last six months
  • Known allergy or skin sensitivity to adhesives or Kinesio Tape materials
  • Current use of medications affecting physical performance or sensation
  • Participation in ongoing physical therapy or rehabilitation
  • Diagnosed cognitive impairment or visual deficits that could affect typing or reaction-time performance
  • Engagement in high-level upper extremity sports (>10 hours/week) that could bias grip or typing performance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Therapeutic Kinesio Taping
Participants receive Kinesio Taping applied to the wrist extensor muscles of the dominant upper extremity using approximately 25% therapeutic tension, following a standardized application protocol.
Elastic therapeutic tape applied to the wrist extensor muscles of the dominant upper extremity using approximately 25% tension according to a standardized application protocol.
Sham Comparator: Sham Kinesio Taping
Participants receive Kinesio Taping applied to the same anatomical region using an identical procedure but without tension, to simulate the intervention without therapeutic effect.
Elastic tape applied to the wrist extensor muscles of the dominant upper extremity without tension, using the same placement and procedure as the therapeutic intervention to mimic sensory and procedural aspects without intended therapeutic effect.
No Intervention: Control Group
Participants do not receive any taping intervention and remain seated in a standardized position for 20 minutes before post-intervention assessments.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal Grip Strength
Time Frame: Baseline and immediately post-intervention (within 2-3 minutes after a 20-minute waiting period)
Maximal grip strength of the dominant hand measured in kilograms using a digital hand dynamometer. The highest value from three trials is recorded.
Baseline and immediately post-intervention (within 2-3 minutes after a 20-minute waiting period)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Typing Performance (Corrected Words Per Minute) and Accuracy
Time Frame: Baseline and immediately post-intervention
Typing speed measured using a standardized computer-based typing task; corrected words per minute calculated by accounting for errors And Typing accuracy measured as the percentage of correct entries during a standardized typing task.
Baseline and immediately post-intervention
Choice Reaction Time
Time Frame: Baseline and immediately post-intervention
Reaction time measured in milliseconds using a computer-based Go/No-Go task, calculated as the mean response time for correct trials.
Baseline and immediately post-intervention
Manual Dexterity (Nine-Hole Peg Test)
Time Frame: Baseline and immediately post-intervention
Fine motor dexterity assessed using the Nine-Hole Peg Test; fastest completion time recorded in seconds.
Baseline and immediately post-intervention
Perceived Performance Visual Analog Scale (VAS)
Time Frame: Immediately post-intervention
Self-reported perceived performance measured using a 100-mm Visual Analog Scale (VAS), where 0 indicates no perceived improvement and 100 indicates maximum perceived improvement. Higher scores indicate better perceived performance.
Immediately post-intervention
Task Ease Visual Analog Scale (VAS)
Time Frame: Immediately post-intervention
Self-reported task ease measured using a 100-mm Visual Analog Scale (VAS), where 0 indicates much harder, 50 indicates no change, and 100 indicates much easier. Higher scores indicate greater perceived ease of task performance.
Immediately post-intervention
Comfort Visual Analog Scale (VAS)
Time Frame: Immediately post-intervention
Self-reported comfort measured using a 100-mm Visual Analog Scale (VAS), where 0 indicates extremely uncomfortable and 100 indicates extremely comfortable. Higher scores indicate greater comfort.
Immediately post-intervention
Global Rating of Change (GRC)
Time Frame: Immediately post-intervention
Participant-reported overall perceived change measured using a 15-point Global Rating of Change (GRC) scale ranging from -7 (vastly worse) to 0 (no change) to +7 (vastly better). Higher scores indicate greater perceived improvement.
Immediately post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Begüm kara Kaya, PhD, Biruni University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

March 31, 2026

First Submitted That Met QC Criteria

March 31, 2026

First Posted (Actual)

April 7, 2026

Study Record Updates

Last Update Posted (Actual)

April 9, 2026

Last Update Submitted That Met QC Criteria

April 6, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Kinesio Taping

Subscribe